TickerFactsScreenerDevelopers

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2007: $1.81B2008: $3.23B2009: $3.37B2010: $4.14B2011: $4.13B2012: $4.57B2013: $3.24B2016: $3.89B2017: $2.23B2018: $2.45B2019: $748.00M2020: $1.22B2021: $798.00M2022: $1.59B2023: $1.37B2024: $1.25B2025: $1.65B$1.65B
2007Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$1.65B+32.2%
2024$1.25B-8.8%
2023$1.37B-14.0%
2022$1.59B+99.2%
2021$798.00M-34.4%
2020$1.22B+62.6%
2019$748.00M-69.4%
2018$2.45B+9.9%
2017$2.23B-42.8%
2016$3.89B—
2013$3.24B-29.2%
2012$4.57B+10.6%
2011$4.13B-0.0%
2010$4.14B+22.6%
2009$3.37B+4.4%
2008$3.23B+78.2%
2007$1.81B—